Lake Street Capital Markets LLC

11/17/2026 | Press release | Distributed by Public on 11/18/2026 12:49

Transaction - Insight Molecular Diagnostics Inc. $15,000,000 Follow-on

Lake Street is pleased to announce that it served as sole bookrunner for Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) in its sale of 8,571,429 shares of common stock (or pre-funded warrants in lieu thereof) in an underwritten public offering at a price per share of $1.75 (or $1.7499 per pre-funded warrant) for gross proceeds of approximately $15.0 million. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes, including but not limited to research and development in the transplantation category.

‍

Want to stay up-to-date with the latest at Lake Street? Subscribe to our mailing list!
NameEmail Address
Thanks for joining our mailing list.
Oops! Something went wrong while submitting the form.
Attachment
Lake Street Capital Markets LLC published this content on November 17, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 18, 2026 at 18:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]